Design, display and immunogenicity of HIV1 gp120 fragment immunogens on virus-like particles

被引:4
|
作者
Purwar, Mansi [1 ]
Pokorski, Jonathan K. [2 ,3 ,6 ]
Singh, Pranveer [1 ,7 ]
Bhattacharyya, Sanchari [1 ]
Arendt, Heather [4 ]
DeStefano, Joanne [4 ]
La Branche, Celia C. [5 ]
Montefiori, David C. [5 ]
Finn, M. G. [2 ,3 ,8 ]
Varadarajan, Raghavan [1 ]
机构
[1] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India
[2] Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA
[4] Int AIDS Vaccine Initiat, Brooklyn, NY 11226 USA
[5] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[6] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA
[7] Mahatma Gandhi Cent Univ Bihar, Dept Zool, Motihari 845401, Bihar, India
[8] Georgia Inst Technol, Sch Chem & Biochem, 901 Atlantic Dr, Atlanta, GA 30332 USA
基金
美国国家卫生研究院;
关键词
Protein stability; Immune focusing; Neutralizing antibodies; Vaccine; Nanoparticles; OUTER-DOMAIN; DISULFIDE BONDS; NEUTRALIZING ANTIBODIES; TYPE-1; VACCINE; CD4; CORE; SITE; GLYCOSYLATION; GLYCOPROTEIN;
D O I
10.1016/j.vaccine.2018.07.032
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The broadly neutralizing antibody against HIV-1, b12, binds to the CD4 binding site (CD4bs) on the outer domain (OD) of the gp120 subunit of HIV-1 Env. We have previously reported the design of an E. coli expressed fragment of HIV-1 gp120, b122a, containing about 70% of the b12 epitope with the idea of focusing the immune response to this structure. Since the b122a structure was found to be only partially folded, as assessed by circular dichroism and protease resistance, we attempted to stabilize it by the introduction of additional disulfide bonds. One such mutant, b122a1-b showed increased stability and bound b12 with 30-fold greater affinity as compared to b122a. Various b122a and OD fragment proteins were displayed on the surface of Qp virus-like particles. Sera raised against these particles in six-month long rabbit immunization studies could neutralize Tier1 viruses across different subtypes with the best results observed with b122a1-b displayed particles. Significantly higher amounts of antibodies directed towards the CD4bs were also elicited by particles displaying b122a1-b. This study highlights the ability of fragment immunogens to focus the antibody response to the conserved CD4bs of HIV-1. (C) 2018 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6345 / 6353
页数:9
相关论文
共 50 条
  • [41] Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity
    Hyakumura, Michiko
    Walsh, Renae
    Thaysen-Andersen, Morten
    Kingston, Natalie J.
    La, Mylinh
    Lu, Louis
    Lovrecz, George
    Packer, Nicolle H.
    Locarnini, Stephen
    Netter, Hans J.
    JOURNAL OF VIROLOGY, 2015, 89 (22) : 11312 - 11322
  • [42] Chimeric Human Papillomavirus-16 Virus-like Particles Presenting HIV-1 P18I10 Peptide: Expression, Purification, Bio-Physical Properties and Immunogenicity in BALB/c Mice
    Chen, Chun-Wei
    Saubi, Narcis
    Joseph-Munne, Joan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [43] Safety and immunogenicity of BPV-1 L1 virus-like particles in a dose-escalation vaccination trial in horses
    Hainisch, E. K.
    Brandt, S.
    Shafti-Keramat, S.
    Van Den Hoven, R.
    Kirnbauer, R.
    EQUINE VETERINARY JOURNAL, 2012, 44 (01) : 107 - 111
  • [44] Design of an Escherichia coli Expressed HIV-1 gp120 Fragment Immunogen That Binds to b12 and Induces Broad and Potent Neutralizing Antibodies
    Bhattacharyya, Sanchari
    Singh, Pranveer
    Rathore, Ujjwal
    Purwar, Mansi
    Wagner, Denise
    Arendt, Heather
    DeStefano, Joanne
    LaBranche, Celia C.
    Montefiori, David C.
    Phogat, Sanjay
    Varadarajan, Raghavan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (14) : 9815 - 9825
  • [45] Differential N- and O-glycosylation signatures of HIV-1 Gag virus-like particles and coproduced extracellular vesicles
    Lavado-Garcia, Jesus
    Zhang, Tao
    Cervera, Laura
    Godia, Francesc
    Wuhrer, Manfred
    BIOTECHNOLOGY AND BIOENGINEERING, 2022, 119 (05) : 1207 - 1221
  • [46] X4 Human Immunodeficiency Virus Type 1 gp120 Down-Modulates Expression and Immunogenicity of Codelivered Antigens
    Hovav, Avi-Hai
    Santosuosso, Michael
    Bivas-Benita, Maytal
    Plair, Andre
    Cheng, Alex
    Elnekave, Mazal
    Righi, Elda
    Chen, Tao
    Kashiwagi, Satoshi
    Panas, Michael W.
    Xiang, Shi-Hua
    Furmanov, Karina
    Letvin, Norman L.
    Poznansky, Mark C.
    JOURNAL OF VIROLOGY, 2009, 83 (21) : 10941 - 10950
  • [47] Conserved Molecular Signatures in gp120 Are Associated with the Genetic Bottleneck during Simian Immunodeficiency Virus (SIV), SIV-Human Immunodeficiency Virus (SHIV), and HIV Type 1 (HIV-1) Transmission
    Gonzalez, Mileidy W.
    DeVico, Anthony L.
    Lewis, George K.
    Spouge, John L.
    JOURNAL OF VIROLOGY, 2015, 89 (07) : 3619 - 3629
  • [48] Development and validation of a quantitation assay for fluorescently tagged HIV-1 virus-like particles
    Gutierrez-Granados, Sonia
    Cervera, Laura
    Godia, Francesc
    Carrillo, Jorge
    Mercedes Segura, Maria
    JOURNAL OF VIROLOGICAL METHODS, 2013, 193 (01) : 85 - 95
  • [49] A broad spectrum anti-HIV inhibitor significantly disturbs V1/V2 domain rearrangements of HIV-1 gp120 and inhibits virus entry
    Berinyuy, Emiliene
    Soliman, Mahmoud E. S.
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2016, 36 (02) : 119 - 129
  • [50] Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells
    Hyoung Jin Kim
    Seo Young Cho
    Min-Hye Park
    Hong-Jin Kim
    Archives of Pharmacal Research, 2018, 41 : 544 - 553